COMMUNIQUÉS West-GlobeNewswire

-
Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency
15/02/2024 - 13:00 -
XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units
15/02/2024 - 13:00 -
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
15/02/2024 - 13:00 -
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
15/02/2024 - 12:30 -
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
15/02/2024 - 12:30 -
Tricha Shivas Promoted to Chief of Staff and Strategy at Foundation for Sarcoidosis Research
15/02/2024 - 12:23 -
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
15/02/2024 - 12:05 -
King Faisal Specialist Hospital & Research Centre Holds Firm as Global and Regional Healthcare Leader
15/02/2024 - 12:03 -
Notice to Convene the Annual General Meeting of Genmab A/S
15/02/2024 - 12:00 -
RadNet and JVS SoCal Create ImagingWorks®, an Innovative Partnership to Launch Career Training Programs for Medical Imaging
15/02/2024 - 12:00 -
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
15/02/2024 - 10:00 -
Ipsen S.A. publie ses comptes consolidés 2023
15/02/2024 - 10:00 -
JOHNSON & JOHNSON MEDTECH LAUNCHES NEW PRESBYOPIA-CORRECTING INTRAOCULAR LENS TECNIS PURESEE IN EMEA
15/02/2024 - 10:00 -
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
15/02/2024 - 08:00 -
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance
15/02/2024 - 07:00 -
Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2023 et fournit des indications préliminaires pour l’exercice 2024
15/02/2024 - 07:00 -
Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023
15/02/2024 - 07:00 -
CARBIOS and De Smet Engineers & Contractors enter engineering partnership for construction of world’s first PET biorecycling plant
15/02/2024 - 06:45 -
CARBIOS et De Smet Engineers & Contractors signent un partenariat d'ingénierie pour la construction de la première usine de biorecyclage de PET au monde
15/02/2024 - 06:45
Pages